Ocugen
Ocugen (NASDAQ: OCGN) is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing transformative therapies to treat the whole eye.
CAGE Code
8JDU2
0
CEO
CIK Number
Legal Name
Ocugen, Inc.
0
Company Operating Status
Active
Contact Page URL
Country
Crunchbase URL
DUNS Number
079212680
0
Founded Date
2013
Founder
Full Address
263 Great Valley Pkwy, Malvern, Pennsylvania 19355, US
11 Great Valley Parkway Malvern, PA 19355
0
Latest Funding Round Date
May 2020
Latest Funding Type
LinkedIn URL
Location
Number of Employees
56
0
Number of Employees (Ranges)
51 – 200
Patents Assigned (Count)
1
Phone Number
+14843284701
0
Pitchbook URL
Place of Incorporation
Previous Name
HISTOGENICS CORP
0
SIC Code
2,836
0
Exchange
Stock Symbol
OCGN
0
Ticker Symbol
OCGN
0
Total Funding Amount (USD)
27,784,119
Twitter URL
Official Website
Find more companies like Ocugen
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
